The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Teva- Pharmaceutical Industries Ltd. ADR shares valued at $1,048,119 were sold by Kalif Eliyahu Sharon on Mar 06 ’24. At $13.52 per share, Kalif Eliyahu Sharon sold 77,550 shares. The insider’s holdings dropped to 203,691 shares worth approximately $2.82 million following the completion of this transaction.
Also, Sabag Mark sold 100,000 shares, netting a total of over 1,352,090 in proceeds. Following the sale of shares at $13.52 each, the insider now holds 382,590 shares.
Before that, Daniell Richard had sold 48,629 shares from its account. In a trade valued at $657,240, the Exec. VP, European Commercial traded Teva- Pharmaceutical Industries Ltd. ADR shares for $13.52 each. Upon closing the transaction, the insider’s holdings decreased to 48,629 shares, worth approximately $0.97 million.
As published in a research note from JP Morgan on March 08, 2024, Teva- Pharmaceutical Industries Ltd. ADR [TEVA] has been rated up from an Underweight to a Neutral and the price target has been revised to $14. Analysts at Piper Sandler upgraded the stock from ‘”a Neutral”‘ to ‘”an Overweight”‘ outlook in a report released in mid February. As of January 23, 2024, Jefferies has increased its “Hold” rating to a “Buy” for TEVA. Earlier on January 03, 2024, Piper Sandler upgraded its rating. Their new recommendation was “a Neutral” for TEVA stock which previously was a “an Underweight”.
Analyzing TEVA Stock Performance
During the last five days, there has been a drop of approximately -1.91%. Over the course of the year, Teva- Pharmaceutical Industries Ltd. ADR shares have jumped approximately 32.66%. Shares of the company reached a 52-week high of $14.47 on 04/08/24 and a 52-week low of $10.45 on 01/02/24. A 50-day SMA is recorded $13.30, while a 200-day SMA reached $10.47. Nevertheless, trading volume fell to 6.19 million shares from 6.72 million shares the previous day.
Support And Resistance Levels for Teva- Pharmaceutical Industries Ltd. ADR (TEVA)
According to the 24-hour chart, there is a support level at 13.77, which, if violated, would cause prices to drop to 13.69. In the upper region, resistance lies at 13.96. The next price resistance is at 14.08. RSI (Relative Strength Index) is 52.93 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -0.03, which suggests the price will decrease in the coming days. Percent R is at 61.81%, indicating low price movement. Stochastics %K at holding indicates that the stock is to be held.
Is Teva- Pharmaceutical Industries Ltd. ADR subject to short interest?
Stocks of Teva- Pharmaceutical Industries Ltd. ADR saw a sharp steep in short interest on Mar 15, 2024 dropping by -4.93 million shares to 10.46 million. Data from Yahoo Finance shows that the short interest on Feb 15, 2024 was 15.39 million shares. A decline of -47.13% in short interest reflects a positive sentiment towards the stock. Despite the fact that short shares comprise just 1.17 of the overall float, the days-to-cover ratio (short ratio) decline to 1.17.
